| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8449252 | European Journal of Cancer Supplements | 2008 | 6 Pages |
Abstract
The three drugs combination of Taxotere, Epirubicin and Fluorouracil is active and well tolerated first-line treatment in advanced gastric cancer patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
F. Giuliani, S. Romito, E. Maiello, A. Capobianco, F. Carrozza, I. Nugnes, A. Misino, M.R. Valerio, L. Manzione, G. Colucci,